CB Insights has indicated that Insurtech startups are poised for historically large investment rounds in 2026, even as the sector confronts a sharply contracting pipeline of fresh opportunities. According to CB Insights’ latest analysis, the median deal size climbed to $10 million in the first quarter—nearly twice the $5.3 million peak recorded during the 2021 funding surge.
Yet overall transaction volume hit a decade-low of just 81 deals, the smallest quarterly tally since mid-2016.
CB Insights also mentioned in the research report that total capital deployed reached $1.6 billion, slightly above the quarterly average since 2023, signaling that money remains available but is concentrating on fewer, more mature players.
This divergence highlights a deeper structural challenge: insurtech is lagging the rest of the venture ecosystem.
Among companies that closed funding in Q1, 82 percent will not be positioned to raise again for at least six months—17 percentage points longer than the broader venture market average.
The wait is the longest when compared with AI, digital health, and fintech verticals. Meanwhile, the global pool of active insurtech investors continues to shrink.
The number of firms completing four or more equity investments in the space fell to a nine-year low in 2025, and the count of active investors in Q1 2026 dropped to its lowest level since late 2020.
The consequences are visible in company performance.
Insurtechs still within their optimal “funding window” expanded headcount by 60.6 percent over the past year, while those whose windows had closed grew by only 4.8 percent.
Prolonged gaps between raises increase the risk of stalled growth, thinner acquisition pipelines for carriers, and higher write-downs for investors.
Compounding the issue is the sharp retreat by insurance industry corporate venture capital (CVC) arms.
Only four insurance-linked CVCs participated in deals during Q1: American Family Ventures, Intact Ventures, Optum Ventures, and Sancor Seguros Ventures—the lowest participation since late 2017. In contrast, ten non-insurance CVCs remained active.
The handful of deals that did occur skewed early-stage: American Family backed contractor-focused managing general agent Comeryx in a $7.5 million seed round and legal-AI platform Qumis in a $4.3 million seed; Intact co-invested in Comeryx;
Optum supported brokerage Gyde’s $60 million Series A; and Sancor participated in Gangkhar’s $4.25 million seed.
Data from CB Insights’ Mosaic scoring system underscores the stakes. CVC-backed insurtechs average a score of 545 out of 1,000—29 percent higher than non-CVC peers—indicating that corporate investors have historically identified stronger companies.
The recent pullback therefore threatens to limit carriers’ early visibility into high-potential startups.
Munich Re’s 2025 acquisition of NEXT, which had ranked in the global top 1 percent with a Mosaic score of 907, illustrates the long-term payoff of sustained CVC engagement.
At the same time, insurance executives are accelerating the shift from AI experimentation to enterprise-wide infrastructure.
Mentions of Anthropic on earnings calls surged 199 percent quarter-over-quarter to 233, closing the gap with OpenAI’s 395 mentions to its narrowest margin yet.
Leaders at Allianz, AIG, and Travelers publicly benchmarked their AI capabilities against Anthropic models and outlined deployments reaching thousands of employees.
Broker Hub International reported embedding Claude across more than 20,000 staff, delivering 85 percent productivity gains in targeted workflows.
For startups, the takeaway is clear: thin AI wrappers layered atop existing platforms face growing obsolescence as carriers adopt foundational models directly. CB Insights has concluded that the most resilient insurtechs will focus on measurable, scalable outcomes—whether through safer AI integration, workflow transformation, or AI-native distribution models that incumbents cannot replicate quickly.
